[IART] Integra LifeSciences Holdings Corporation


Type of security: Stock

Sector: Capital Goods

Industry: Biotechnology: Laboratory Analytical Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 85.91 Change: 0.57 (0.67%)
Ext. hours: Change: 0 (0%)

chart IART

Refresh chart

Strongest Trends Summary For IART

IART is in the long-term up 319% in 13 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. Its orthopedics products include specialty metal implants for surgery of the extremities, shoulder, and spine; orthobiologic products for repair and grafting of bone, including demineralized bone products, collagen ceramic matrices, and synthetic bone grafting solutions; dermal regeneration products and tissue-engineered wound dressings; and nerve and tendon repair products. The company also offers spinal fusion technologies comprising integrated interbody fusion devices, minimally invasive solutions, and deformity correction products; and neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devi

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 1% Sales Growth - Q/Q-7.34% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA2.59% ROE5.84% ROI3.02%
Current Ratio4.12 Quick Ratio2.28 Long Term Debt/Equity1.55 Debt Ratio0.18
Gross Margin62.28% Operating Margin7.77% Net Profit Margin4.24% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities30.45 M Cash From Investing Activities-18.74 M Cash From Operating Activities49.74 M Gross Profit157.54 M
Net Profit5 M Operating Profit13.95 M Total Assets1.64 B Total Current Assets608.25 M
Total Current Liabilities155.75 M Total Debt654.14 M Total Liabilities926.17 M Total Revenue244.08 M
Technical Data
High 52 week65.87 Low 52 week42.62 Last close61.85 Last change2.11%
RSI53.53 Average true range1.4 Beta0.67 Volume390.34 K
Simple moving average 20 days2.95% Simple moving average 50 days2.07% Simple moving average 200 days13.93%
Performance Data
Performance Week6.77% Performance Month1.76% Performance Quart14.66% Performance Half17.45%
Performance Year-3.1% Performance Year-to-date37.14% Volatility daily1.4% Volatility weekly3.13%
Volatility monthly6.42% Volatility yearly22.25% Relative Volume322.8% Average Volume416.06 K
New High New Low


2021-04-08 16:00:00 | Integra LifeSciences to Host First Quarter 2021 Financial Results Conference Call on April 28, 2021

2021-04-03 05:30:56 | Is Integra LifeSciences Holdings Corporation's NASDAQ:IART 8.8% ROE Worse Than Average?

2021-04-01 16:15:00 | Integra LifeSciences Appoints Shaundra Clay as Director

2021-03-31 10:41:02 | Here's Why You Should Retain Integra LifeSciences IART Stock

2021-03-31 09:08:01 | Integra's IART Neurosurgery Rebounds Despite Supply Issues

2021-03-22 05:33:09 | Veeva VEEV Partners With Impel, Boosts Cloud-Based Offerings Revised

2021-03-20 11:30:03 | Integra IART Down 3% Since Last Earnings Report: Can It Rebound?

2021-03-10 09:24:02 | Integra IART Neurosurgery Grows Sequentially Amid Supply Woe

2021-02-25 23:36:23 | Integra LifeSciences Holdings Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

2021-02-19 08:00:00 | Integra LifeSciences Announces Participation in Upcoming Investor Conferences

2021-02-18 16:00:43 | Integra Lifesciences Holdings Corp IART Q4 2020 Earnings Call Transcript

2021-02-18 07:47:04 | Recap: Integra Lifesciences Q4 Earnings

2021-02-18 06:30:00 | Integra LifeSciences Holdings Corp. to Host Earnings Call

2021-02-18 06:00:00 | Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides 2021 Financial Guidance

2021-02-12 07:50:12 | Veeva VEEV Partners With Impel, Boosts Cloud-Based Offerings

2021-02-09 02:00:47 | Calculating The Intrinsic Value Of Integra LifeSciences Holdings Corporation NASDAQ:IART

2021-01-21 09:29:02 | Integra IART Acquires Acell, Focuses on Regenerative Space

2021-01-20 08:40:00 | Integra LifeSciences Completes the Acquisition of ACell, Inc.

2021-01-15 08:35:01 | Integra IART Preliminary Q4 Reported Sales Show Recovery

2021-01-14 06:30:00 | Integra LifeSciences Announces Preliminary Fourth Quarter and Full-Year 2020 Revenue Results; Will Host Fourth Quarter Financial Results Conference Call on February 18, 2021

2021-01-06 13:30:06 | NEOGEN NEOG Fortifies Global Position via Megazyme Buyout

2021-01-06 09:29:02 | Hologic HOLX Completes SOMATEX Buyout, Expands Portfolio

2021-01-05 10:02:03 | Integra IART Sells Unprofitable Arm to Focus on Core Business

2021-01-04 12:49:00 | Integra LifeSciences Completes the Sale of its Extremity Orthopedics Business to Smith+Nephew

2020-12-31 09:26:02 | Integra IART Hits New 52-Week High: What's Driving It?

2020-12-29 10:36:03 | Integra IART to Buy ACell, Expand Regenerative Capability

2020-12-26 03:33:20 | Does Integra LifeSciences Holdings' NASDAQ:IART Share Price Gain of 96% Match Its Business Performance?

2020-12-21 16:01:00 | Integra LifeSciences to Present at 39th Annual J.P. Morgan Healthcare Conference

2020-12-16 08:00:00 | Integra LifeSciences Announces Definitive Agreement to Acquire ACell, Inc.

2020-12-15 20:39:51 | Is IART A Good Stock To Buy Now?

2020-12-08 12:46:05 | Should Value Investors Pick Integra LifeSciences IART Now?

2020-11-27 11:31:04 | Integra IART Up 24% Since Last Earnings Report: Can It Continue?

2020-11-11 08:28:58 | How Much Is Integra LifeSciences Holdings' NASDAQ:IART CEO Getting Paid?

2020-10-29 11:20:03 | Integra IART Q3 Earnings Surpass Estimates, Margins Up

2020-10-28 17:30:38 | Integra Lifesciences Holdings Corp IART Q3 2020 Earnings Call Transcript

2020-10-28 07:30:11 | Integra LifeSciences IART Tops Q3 Earnings and Revenue Estimates

2020-10-28 07:21:19 | Integra Lifesciences: Q3 Earnings Insights

2020-10-28 06:30:00 | Integra LifeSciences Holdings Corp. to Host Earnings Call

2020-10-28 06:00:00 | Integra LifeSciences Reports Third Quarter 2020 Financial Results

2020-10-21 12:32:04 | Earnings Preview: Integra LifeSciences IART Q3 Earnings Expected to Decline

2020-10-14 11:40:03 | IART vs. ABMD: Which Stock Is the Better Value Option?

2020-10-08 03:37:15 | Integra Jumps 6% On Raised 3Q Sales Outlook

2020-10-07 10:42:02 | Integra IART Preliminary Q3 Results Show Recovery in Sales

2020-10-07 09:00:59 | Hedge Funds Dipping Their Toes Into Integra Lifesciences Holdings Corp IART

2020-10-07 07:30:09 | The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences

2020-10-06 16:01:00 | Integra LifeSciences Announces Preliminary Third Quarter Revenue Results; Will Host Third Quarter 2020 Financial Results Conference Call on October 28, 2020

2020-09-29 11:56:00 | Integra to Sell Orthopedics Line to Smith & Nephew for $240M

2020-09-29 09:02:00 | Smith+Nephew expands in higher-growth extremities segment through planned acquisition of Integra LifeSciences' Extremity Orthopaedics business

2020-09-29 08:00:00 | Integra LifeSciences Announces Definitive Agreement to Divest its Extremity Orthopedics Business to Smith+Nephew for $240 Million

2020-09-20 20:00:00 | Market Digest: THRM, IART